Luminex's Q2 Revenues Increase 19 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Thursday that its second-quarter revenues rose 19 percent, with double-digit increases for its systems and consumables sales.

The Austin, Texas-based maker of multiplex systems for research and diagnostics brought in total revenues of $33.2 million for the three months ended June 30, up 19 percent from $27.8 million for Q2 2009. It fell just short of analysts' consensus estimate of $33.6 million in revenues for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.

Researchers explore using genome editing to treat inherited eye diseases, New Scientist reports.

Olympic athletes this summer will also undergo gene doping testing, according to Wired.

A study finds that the lower funding rate seen among women of color is more due to race than gender, according to BuzzFeed News.